Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,584.00
(
0.11%
)
Dow Jones
49,247.66
(
-0.13%
)
Brent Oil
101.74
(
0.20%
)
Bitcoin
77,839.58
(
-1.04%
)
News Focus
News Focus
Post# of 257443
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122886
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: mcbio post# 130938

Sunday, 11/13/2011 2:13:46 PM

Sunday, November 13, 2011 2:13:46 PM

Post# of 257443

Do you still consider IDIX a potential short candidate or does the surprising acquisition of ANDS maybe cause you to back off those thoughts a bit?

Yes, too dangerous, IMO—not so much because of Roche’s acquisition of ANDS, but rather because of the large pop in INHX ‘s share price from reporting interim phase-2 data that I would describe as pedestrian.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today